Category: Chemotherapy
-
Mesothelioma Researchers and Oncology Pharmaceutical Companies Invited to Attend Upcoming FDA Orphan Drug Workshop
Mesothelioma is a unique and rare form of cancer, typically affecting the lining of the lungs, caused by exposure to asbestos fibers. The cancer is highly aggressive and is resistant to many standard cancer treatments making it a difficult disease to treat effectively. Mesothelioma is diagnosed in 3,000 Americans each year, and due to the …
Label: Chemotherapy
Posted on Tuesday, Feb 1, 2011 -
Mesothelioma Patients May Benefit from Retreatment of Chemotherapy
Malignant pleural mesothelioma is a unique, rare asbestos-related pulmonary cancer that is highly aggressive and is resistant to many standard cancer treatments. It can be treated with varying degrees of success, however, through the use of surgical procedures, chemotherapy and radiation. The current chemotherapy standard of care for the treatment of pleural mesothelioma is combination …
Label: Chemotherapy
Posted on Monday, Jan 31, 2011 -
Gastric Cancer Drug Shows Potential for Treating Pleural Mesothelioma
Malignant pleural mesothelioma patients may soon have another treatment option if the makers of Teysuno, a gastric cancer drug, can prove the effectiveness of the drug in fighting the deadly form of lung cancer. Mesothelioma is a rare, aggressive respiratory cancer caused by exposure to airborne asbestos fibers and is resistant to many standard cancer …
Label: Chemotherapy
Posted on Tuesday, Jan 11, 2011
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.